Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indisulam + Capecitabine vs Capecitabine in Metastatic Breast Cancer
NCT00165880Phase 2Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2004
- Modality
- RNA-Targeting Small Molecules, Molecular Glues
- Countries
- 5
01
Overview
A Phase 2 trial of indisulam in breast cancer, sponsored by Eisai Co., Ltd.. Started Dec 2004; status: terminated.
02
Drugs
indisulam
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00165880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165880.